Display options
Share it on

Adv Pharm Bull. 2016 Mar;6(1):17-21. doi: 10.15171/apb.2016.004. Epub 2016 Mar 17.

Sustained release Curcumin loaded Solid Lipid Nanoparticles.

Advanced pharmaceutical bulletin

Parisa Jourghanian, Solmaz Ghaffari, Mehdi Ardjmand, Setareh Haghighat, Mahdieh Mohammadnejad

Affiliations

  1. Department of Chemical Engineering, Shahrood Branch, Islamic Azad University, Shahrood, Iran.
  2. Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Pharmaceutical Sciences Branch, Islamic Azad University, (IAUPS), Tehran, Iran.; Young Researchers and Elite Club, Pharmaceutical Sciences Branch, Islamic Azad University, (IAUPS), Tehran, Iran.
  3. Department of Chemical Engineering, South Tehran Branch, Islamic Azad University, Tehran, Iran.
  4. Department of Microbiology, Faculty of Advanced Sciences and Technology, Pharmaceutical Sciences Branch, Islamic Azad University (IAUPS), Tehran, Iran.
  5. Quality Control Department, Tofigh Daru Research and Engineering Co. Tehran, Iran.

PMID: 27123413 PMCID: PMC4845547 DOI: 10.15171/apb.2016.004

Abstract

PURPOSE: curcumin is poorly water soluble drug with low bioavailability. Use of lipid systems in lipophilic substances increases solubility and bioavailability of poorly soluble drugs. The aim of this study was to prepare curcumin loaded Solid Lipid Nanoparticles (SLNs) with high loading efficiency, small particle size and prolonged release profile with enhanced antibacterial efficacy.

METHODS: to synthesize stable SLNs, freeze- Drying was done using mannitol as cryoprotectant. Cholesterol was used as carrier because of good tolerability and biocompatibility. SLNs were prepared using high pressure homogenization method.

RESULTS: optimized SLNs had 112 and 163 nm particle size before and after freeze drying, respectively. The prepared SLNs had 71% loading efficiency. 90% of loaded curcumin was released after 48 hours. Morphologic study for formulation was done by taking SEM pictures of curcumin SLNs. RESULTS show the spherical shape of curcumin SLNs. DSC studies were performed to determine prolonged release mechanism. Antimicrobial studies were done to compare the antimicrobial efficacy of curcumin SLNs with free curcumin. DSC studies showed probability of formation of hydrogen bonds between cholesterol and curcumin which resulted in prolonged release of curcumin. Lipid structure of cholesterol could cause enhanced permeability in studied bacteria to increase antibacterial characteristics of curcumin.

CONCLUSION: the designed curcumin SLNs could be candidate for formulation of different dosage forms or cosmeceutical products.

Keywords: Curcumin; Freeze drying; Particle size; Solid Lipid Nanoparticles; Sustained release

References

  1. Biomed Res Int. 2014;2014:186864 - PubMed
  2. Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):165-96 - PubMed
  3. Free Radic Biol Med. 2006 Apr 1;40(7):1152-60 - PubMed
  4. Eur J Pain. 2015 Aug;19(7):940-52 - PubMed
  5. Anticancer Drugs. 1997 Jun;8(5):470-81 - PubMed
  6. Curr Med Chem. 2014;21(14):1583-94 - PubMed
  7. Antimicrob Agents Chemother. 2009 Apr;53(4):1592-7 - PubMed
  8. J Liposome Res. 2010 Jun;20(2):97-104 - PubMed
  9. Phytomedicine. 2013 Jun 15;20(8-9):714-8 - PubMed
  10. Mater Sci Eng C Mater Biol Appl. 2013 Dec 1;33(8):4802-8 - PubMed
  11. Int J Nanomedicine. 2010 Dec 16;6:35-43 - PubMed
  12. Cancer. 2005 Sep 15;104(6):1322-31 - PubMed
  13. Nanomedicine. 2015 Jan;11(1):195-206 - PubMed
  14. AAPS J. 2009 Sep;11(3):495-510 - PubMed
  15. Molecules. 2012 May 18;17(5):5972-87 - PubMed
  16. Colloids Surf B Biointerfaces. 2013 Nov 1;111:367-75 - PubMed

Publication Types